Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
33.62
-1.74 (-4.92%)
Apr 1, 2025, 4:00 PM EDT - Market closed
Revolution Medicines Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
534
Market Cap
6.25B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
RVMD News
- 1 day ago - Revolution Medicines to Participate in April 2025 Investor Conferences - GlobeNewsWire
- 4 weeks ago - Revolution Medicines, Inc. (RVMD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate Progress - GlobeNewsWire
- 5 weeks ago - Revolution Medicines to Participate in March 2025 Investor Conferences - GlobeNewsWire
- 5 weeks ago - Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2024 After Market Close on February 26, 2025 - GlobeNewsWire
- 2 months ago - Revolution Medicines to Participate in the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewsWire
- 3 months ago - Revolution Medicines to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire